Skip to main content
background gradient

Volume 13Issue 6

Editorial

Open Access
EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out?
  • Alejandra Castanon,
  • Rebecca Sloan,
  • Luisamanda Selle Arocha, and
  • Sreeram V Ramagopalan
e240052
Published Online:2 May 2024
Open Access
Access in all areas? a round up of developments in market access and health technology assessment: part 4
  • Alice Beattie,
  • Catrin Treharne, and
  • Sreeram V Ramagopalan
e240060
Published Online:22 April 2024
Preview Abstract

Short Report

Open Access
Polymer-based drug-eluting stent treatment extends the time to reintervention for patients with symptomatic femoropopliteal artery disease: clinical evidence and potential economic value
  • William A Gray,
  • Yoshimitsu Soga,
  • Masahiko Fujihara,
  • Osamu Iida,
  • Anvar Babaev,
  • Daizo Kawasaki,
  • Thomas Zeller,
  • David O'Connor,
  • Michael R Jaff,
  • Anna M Chavez, and
  • Stefan Müller-Hülsbeck
e240025
Published Online:12 April 2024
Preview Abstract

Research Article

Open Access
Comparing the outcomes and costs of cardiac monitoring with implantable loop recorders and mobile cardiac outpatient telemetry following stroke using real-world evidence
  • Vincent Norlock,
  • Reynaldo Vazquez,
  • Alexandria Dunn,
  • Christian Siegfried,
  • Manish Wadhwa, and
  • Goran Medic
e240008
Published Online:11 April 2024
Preview Abstract
Open Access
Progress of patients hospitalized with acute heart failure treated with empagliflozin
  • Manuel Raya-Cruz,
  • Javier Gascón Jurado,
  • Gonzalo Olalla de la Torre Peregrín,
  • Nicolás Montúfar,
  • Agustín Rodríguez Sánchez, and
  • Francisco Gómez Delgado
e240027
Published Online:24 May 2024
Preview Abstract
Open Access
Cost–effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failure
  • Jaehong Kim,
  • Shanshan Wang,
  • Slaven Sikirica, and
  • Jason Shafrin
e230190
Published Online:21 May 2024
Preview Abstract
Open Access
Healthcare resource utilization and costs among patients with alpha-1 antitrypsin deficiency with liver and/or lung disease: a longitudinal retrospective study in the USA
  • May Hagiwara,
  • Victoria Divino,
  • Swapna Munnangi,
  • Mark Delegge,
  • Suna Park,
  • Ed G Marins,
  • Kaili Ren, and
  • Charlie Strange
e230186
Published Online:2 May 2024
Preview Abstract

Systematic Review

Open Access
A clinical systematic literature review of treatments among patients with advanced and/or metastatic human epidermal growth factor receptor 2 positive breast cancer
  • Kerigo Ndirangu,
  • Rachel Goldgrub,
  • Vanita Tongbram,
  • Rajee Antony,
  • Bagrat Lalayan,
  • Joyce O'Shaughnessy, and
  • Sarah E Schellhorn
e230153
Published Online:29 May 2024
Preview Abstract